These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 809069)

  • 21. Combined radiotherapy and chemotherapy for treatment of unresectable and or metastatic cancer.
    Glenn EH; Cole D; Wunderlich HO
    Int J Clin Pharmacol; 1974 Jan; 9(1):37-40. PubMed ID: 4593128
    [No Abstract]   [Full Text] [Related]  

  • 22. [Role of chemotherapy in the treatment of malignant ovarian tumors].
    Netschajewa ID
    Zentralbl Gynakol; 1971 Nov; 93(48):1659-62. PubMed ID: 5004193
    [No Abstract]   [Full Text] [Related]  

  • 23. Acute hematologic feasibility of G-CSF supported dose-escalated FEC therapy as adjuvant treatment after breast cancer surgery.
    Ottosson S; Magnusson K; Hultborn R
    Anticancer Res; 1999; 19(5C):4429-34. PubMed ID: 10650787
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Clinical efficacy analysis of chemotherapy to lymph node metastasis in epithelial ovarian cancer].
    Wu LY; Zhang R; Huang MN; Li N; Wang GX; Liu LY
    Ai Zheng; 2003 Apr; 22(4):424-7. PubMed ID: 12704005
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Variations in responsiveness and survival of clinical subsets of patients with metastatic breast cancer to two chemotherapy combinations.
    Smalley RV; Bartolucci AA
    Eur J Cancer (1965); 1980; Suppl 1():141-6. PubMed ID: 7318861
    [No Abstract]   [Full Text] [Related]  

  • 26. Cyclic combination chemotherapy for metastatic breast cancer.
    Biran S; Krasnokuki D; Hochman A; Brufman G
    Isr J Med Sci; 1977 Jun; 13(6):582-6. PubMed ID: 885710
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Endolymphatic polychemotherapy of cancer of the ovaries].
    Pankov AK; Sidorenko IuS; Il'inskaia EG; Birbraer VM
    Vopr Onkol; 1975; 21(4):55-7. PubMed ID: 812260
    [No Abstract]   [Full Text] [Related]  

  • 28. Quadrichemotherapy for advanced ovarian carcinoma.
    Kessinger A; Foley JF; Lemon HM
    Obstet Gynecol; 1976 Aug; 48(2):134-6. PubMed ID: 940644
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Combination chemotherapy using cyclophosphamide, vincristine, methotrexate, 5-fluorouracil, and prednisone in solid tumors.
    Bearden JD; Coltman CA; Moon TE; Costanzi JJ; Saiki JH; Balcerzak SP; Rivkin SE; Morrison FS; Lane M; Spigel SC
    Cancer; 1977 Jan; 39(1):21-6. PubMed ID: 832235
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chemotherapy in advanced ovarian cancer.
    Smith JP; Rutledge FN
    Natl Cancer Inst Monogr; 1975 Oct; 42():141-3. PubMed ID: 825776
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combination chemotherapy for advanced mammary carcinoma: a twelve-year experience.
    Greenspan EM
    Mt Sinai J Med; 1972; 39(5):435-46. PubMed ID: 4628078
    [No Abstract]   [Full Text] [Related]  

  • 32. [Current status of chemotherapy of malignant tumors of the ovaries].
    Nechaeva ID
    Vopr Onkol; 1968; 14(6):108-22. PubMed ID: 4972640
    [No Abstract]   [Full Text] [Related]  

  • 33. [Therapy of metastasizing solid tumors with cyclophosphamide, methotrexate, vincristine and 5-fluorouracil].
    Fritsch H; Castor H; Drings P; Moskwa G
    Verh Dtsch Ges Inn Med; 1973; 79():1373-6. PubMed ID: 4790188
    [No Abstract]   [Full Text] [Related]  

  • 34. Combination chemotherapy in disseminated solid tumours.
    Klaassen DJ
    Int J Clin Pharmacol; 1974 Jan; 9(1):41-5. PubMed ID: 4593129
    [No Abstract]   [Full Text] [Related]  

  • 35. Chemotherapy in breast cancer.
    Hanham IW
    Proc R Soc Med; 1974 Apr; 67(4):292-4. PubMed ID: 4453579
    [No Abstract]   [Full Text] [Related]  

  • 36. Individual cell biology: basis and prospects for a rational cancer chemotherapy.
    Tanneberger S
    Arch Geschwulstforsch; 1977; 47(8):755-65. PubMed ID: 345995
    [No Abstract]   [Full Text] [Related]  

  • 37. The role of chemotherapy in the treatment of cancer of the breast.
    Carbone PP
    Am J Clin Pathol; 1975 Dec; 64(6):774-9. PubMed ID: 812356
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The growth of human tumours in immunosuppressed mice and their response to chemotherapy.
    Berenbaum MC; Sheard CE; Reittie JR; Bundick RV
    Br J Cancer; 1974 Jul; 30(1):13-32. PubMed ID: 4213444
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical immunologic responsiveness in malignant disease. I. Delayed hypersensitivity reaction and the effect of cytotoxic drugs.
    Al-Sarraf M; Wong P; Sardesai S; Vaitkevicius VK
    Cancer; 1970 Aug; 26(2):262-8. PubMed ID: 5451212
    [No Abstract]   [Full Text] [Related]  

  • 40. [Determination of the individual sensitivity of ovarian ascitic cancer cells in vitro by cytological criteria].
    Shuvaeva NI; Antoshechkina ET; Klimanova ZF
    Vopr Onkol; 1979; 25(7):101-4. PubMed ID: 113933
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.